Hong Kong Island, Hong Kong, China | Fund Name | Location |
| Centre for the Development of Industrial Technology (CDTI) | Madrid, Madrid, Spain |
| Coriant America | Chelmsford, Massachusetts, United States |
| Formula Ventures | Israel, Tel Aviv, Tel Aviv District |
| Heyi Asset Management | China, Shanghai |
| InterGen Capital | Alberta, Calgary, Canada |
| Knorr Capital Partner | Bavaria, Germany, Munich |
| LAC | Japan, Tokyo |
| North River Ventures | New York, New York, United States |
| Novozymes | Bagsværd, Denmark, Hovedstaden |
| Prudential Capital Partners | Chicago, Illinois, United States |
| Qianyuan Capital | Beijing, Beijing, China |
| SANTACO | Gauteng, Pretoria, South Africa |
| Shanghai Zhenhe | China, Shanghai |
| Taurus Ventures | California, San Francisco, United States |
| Tech Invest Com | Ar Riyad, Riyadh, Saudi Arabia |
| Tern | England, London, United Kingdom |
| Thermo Fisher Scientific | Massachusetts, United States, Waltham |
| VentureCrowd | Australia, New South Wales, Sydney |
| Zibo Qixin | China, Qingdao Shi, Shandong |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bluejay Therapeutics | $182M | 09 May 2024 | - | ||
| $100M | 18 Mar 2021 | Shanghai, China | |||
Botkin.AI | $2M | 23 Dec 2020 | Moscow, Moscow, Russia |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bluejay Therapeutics | $182M | 09 May 2024 | - | ||
| $100M | 18 Mar 2021 | Shanghai, China | |||
Botkin.AI | $2M | 23 Dec 2020 | Moscow, Moscow, Russia |
